US-based clinical trial technology specialist Paradigm Health has agreed to purchase Roche-owned Flatiron Health’s clinical research division. Through this acquisition, Paradigm will integrate ...
COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 /PRNewswire/ -- Paradigm Health, the technology company rebuilding the clinical research ecosystem, today announced an oversubscribed $78 million Series B ...
Partnership creates the largest oncology research network in the United States, enabling clinical trials to reach rural and community-based practices COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 ...
“Our team has been convinced of the need for a paradigm shift in clinical research for years, especially with a focus on improving equitable access. Our name reflects the change that we want to create ...
Tech-enabled clinical research platform Paradigm Health has secured $78 million in an oversubscribed Series B financing round and announced its acquisition of oncology-focused digital health company ...
Paradigm, a tech company that aims to integrate clinical trials more broadly into the healthcare system, launched Jan. 27 with a $203 million series A funding round co-led by venture capital firm ...
Paradigm Health is transforming how clinical trials are conducted and broadening access for patients across the U.S. and globally. The new funding will be used to accelerate Paradigm Health's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback